[Carbochromen in therapy of acute and chronic coronary insufficiency].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D004562:Electrocardiography; D005080:Exercise Test; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D005996:Nitroglycerin / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D010208:Papaverine / Q000627:therapeutic use; D011299:Prenylamine / Q000627:therapeutic use; D013546:Sweating; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D014665:Vasodilator Agents; D010208:Papaverine; D005996:Nitroglycerin; D011299:Prenylamine
Carbochromen in der Therapie der akuten und chronischen Coronarinsuffizienz.